English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
How breast cancer usurps the powers of mammary stem cells
How breast cancer usurps the powers of mammary stem cells
Discovery of role of molecular clocks in tumour growth may impact breast cancer treatment
Discovery of role of molecular clocks in tumour growth may impact breast cancer treatment
Recent use of some birth control pills may increase breast cancer risk
Recent use of some birth control pills may increase breast cancer risk
ASH report: Deep budget cuts have devastating impact on biomedical research in US
ASH report: Deep budget cuts have devastating impact on biomedical research in US
Trastuzumab emtansine superior to physicians’ preferred treatments in pre-treated advanced HER2 positive breast cancer
Trastuzumab emtansine superior to physicians’ preferred treatments in pre-treated advanced HER2 positive breast...
Tamoxifen gel effective when applied to breast, with fewer side effects than oral tamoxifen
Tamoxifen gel effective when applied to breast, with fewer side effects than oral tamoxifen
Leukaemia gene provides clue to treating triple negative breast cancer
Leukaemia gene provides clue to treating triple negative breast cancer
ESMO welcomes the adoption of the Clinical Trials Regulation by the European Union
ESMO welcomes the adoption of the Clinical Trials Regulation by the European Union
ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer
ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in...
ASCO 2014: Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer
ASCO 2014: Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone...
<1...8384858687...105>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top